64 M. Raguindin et al.: J Extra Corpor Technol 2026, 58, 57--64
4. Burstein B, Wieruszewski P, Zhao Y, Smischney N. Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation. World J Crit Care Med. 2019; 8( 6): 87--98.
5. McMichael A, Ryerson L, Ratano D, Fan E, Faraoni D, Annich G. 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J. 2022; 68( 3): 303--310.
6. Rivosecchi R, Arakelians A, Ryan J, et al. Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: Heparin versus bivalirudin. Crit Care Med. 2021; 49:1129--1136.
7. Ranucci M, Ballotta A, Kandil H, et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Crit Care. 2011; 15: R275.
8. Kaseer H, Soto-Arenall M, Sanghavi D, et al. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. J Card Sug. 2020; 35:779--786.
9. Sanfilippo F, Asmussen S, Maybauer D, et al. Bivalirudin for alternative anticoagulation in extracorporeal membrane oxygenation: A systematic review. J Inten Care Med. 2017; 32( 5): 312--319.
10. Netley J, Roy J, Greenlee J, et al. Bivalirudin anticoagulation dosing protocol for extracorporeal membrane oxygenation: A retrospective review. J Extra Corpor Technol. 2018; 50:161--166.
11. Trigonis R, Smith N, Porter S, et al. Efficacy of bivalirudin for therapeutic anticoagulation in COVID-19 patients requiring ECMO support. J Cardiothorac Vasc Anesth. 2022; 36:414--418.
12. Bissell B, Gabbard T, Sheridan E, et al. Evaluation of bivalirudin as the primary anticoagulant in patients receiving extracorporeal membrane oxygenation for SARS-CoV-2-associated acute respiratory failure. Ann Pharmacother, 2022; 56( 4): 387--392.
13. Kidney Disease: Improving Global Outcomes( KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024; 105( 4S): S117--S314.
14. Silva B, Cordioli R, Santos B, et al. COVID-19-associated coagulopathy and acute kidney injury in critically ill patients. Einstein. 2023; 21: eAO0119.
Cite this article as: Raguindin M, Bardsley C, Bast C, Sugrue D, Kazmi H & Milkovits A. Evaluation of bivalirudin-based anticoagulation for extracorporeal membrane oxygenation, including patients with COVID-19. J Extra Corpor Technol 2026, 58, 57--64. https:// doi. org / 10.1051 / ject / 2025045.